CLSD - Clearside Biomedical, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 77.70M
Enterprise value 37.50M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)77.45
Price/book (mrq)28.78
Enterprise value/revenue 38.11
Enterprise value/EBITDA -1.29

Trading information

Stock price history

Beta (5Y monthly) 2.08
52-week change 3-6.67%
S&P500 52-week change 36.21%
52-week high 31.8550
52-week low 30.9000
50-day moving average 31.0908
200-day moving average 31.2192

Share statistics

Avg vol (3-month) 3179.17k
Avg vol (10-day) 390.83k
Shares outstanding 561.67M
Implied shares outstanding 6N/A
Float 853.69M
% held by insiders 17.45%
% held by institutions 128.13%
Shares short (14 May 2023) 4568.37k
Short ratio (14 May 2023) 44.79
Short % of float (14 May 2023) 40.99%
Short % of shares outstanding (14 May 2023) 40.92%
Shares short (prior month 13 Apr 2023) 4269.61k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-3,072.76%

Management effectiveness

Return on assets (ttm)-46.80%
Return on equity (ttm)-201.05%

Income statement

Revenue (ttm)984k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-98.80%
Gross profit (ttm)1.12M
EBITDA -30.12M
Net income avi to common (ttm)-34.58M
Diluted EPS (ttm)-0.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.42M
Total cash per share (mrq)0.67
Total debt (mrq)1.22M
Total debt/equity (mrq)45.30
Current ratio (mrq)8.54
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-24.45M
Levered free cash flow (ttm)-17.35M